@katherined Did you read that whole thread? Apparently it's hitting other insulin providers in a similar manner, because now it's got everyone's attention.

@elazar Yep. Bringing that conversation back to the forefront in such an awkward way is not going to be a good look for any of them.

Sign in to participate in the conversation
Librem Social

Librem Social is an opt-in public network. Messages are shared under Creative Commons BY-SA 4.0 license terms. Policy.

Stay safe. Please abide by our code of conduct.

(Source code)

image/svg+xml Librem Chat image/svg+xml